Status:
COMPLETED
Health Expenses and Outcomes of the DASH Diet in Egyptian Patients With Hypertension
Lead Sponsor:
Beni-Suef University
Conditions:
Hypertension,Essential
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
DASH diet can reduce hypertension and decrease health expenses
Detailed Description
Hypertension is a prevalent cardiovascular risk factor associated with adverse outcomes and obesity. Egypt's prevalence is 26.3%, exceeding rates in the U.S. and sub-Saharan Africa. Lifestyle interven...
Eligibility Criteria
Inclusion
- patients diagnosed with primary hypertension (all stages) in the family medicine units of Esna Health Administration, located in Luxor Governorate.
- Individuals between the ages of 30 and 60, of both male and female genders.
Exclusion
- • Patients with cancer and either hepatic failure or renal impairment.
- Patients diagnosed with diabetes, metabolic illness, or terminal organ failure.
- A patient with severe or malignant hypertension.
- Individuals who decline to partake in our research.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2024
Estimated Enrollment :
364 Patients enrolled
Trial Details
Trial ID
NCT06499194
Start Date
January 1 2023
End Date
June 29 2024
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Banī Suwayf, Egypt, 621125